Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised

Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised

ABSTRACTObjective The aim of the present study is to examine the accuracy of the Brazilian versions of the Montreal Cognitive Assessment (MoCA) and the Addenbrooke's Cognitive Examination-Revised (ACE-R) to screen for mild cognitive impairment (PDMCI) and dementia (PDD) in patients with Parkins...

Full description

Bibliographic Details
Main Authors: Emmanuelle Sobreira, Márcio A. Pena-Pereira, Alan L. Eckeli, Manoel A. Sobreira-Neto, Marcos H. N. Chagas, Maria P. Foss, Brenna Cholerton, Cyrus P. Zabetian, Ignacio F. Mata, Vitor Tumas
Format: Article
Language:English
Published: Academia Brasileira de Neurologia (ABNEURO) 2015-11-01
Series:Arquivos de Neuro-Psiquiatria
Subjects:
MoCA
ACE-R
doença de Parkinson
comprometimento cognitivo leve
demência
avaliação cognitiva
testes neuropsicológicos
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015001100929&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015001100929&lng=en&tlng=en

Similar Items